S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7229 −0.32%
CLOSED · 15:40 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead

KYMR

Kymera Therapeutics, Inc.
NASDAQ · HEALTH CARE · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
117.39
+0.11 +0.09%
USD · Sep 6, 01:16 a.m. ET

Insider trading

SEC FORM 4 · OPEN-MARKET ONLY
−$744K
Net, 90 days
0 / 3
Buys / sells, 90 days
0
Distinct buyers
$0
Bought, 90 days
TradedFiledInsiderTypeSharesPriceValue
Sep 4Sep 4Adams Brian · Chief Legal OfficerSell2,137$117.57$251K
Sep 4Sep 4Adams Brian · Chief Legal OfficerSell3,025$116.81$353K
Sep 4Sep 4Adams Brian · Chief Legal OfficerSell1,209$115.55$140K

Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.

Watch KYMR. Know when insiders buy.
One email the day a filing lands. Free.